Search Results
Found 1 results
510(k) Data Aggregation
(214 days)
LunulaLaser
The LunulaLaser™ device is indicated for use for the temporary increase of clear nail in patients with onychomyosis (e.g., dermatophytes Trichophyton rubrum and T. mentagrophytes, and/or yeasts Candida albicans, etc.)
Not Found
This document is a 510(k) clearance letter for the LunulaLaser, a Class II medical device. It does not provide information on acceptance criteria or a study that proves the device meets those criteria. Instead, it confirms that the FDA reviewed the premarket notification and determined the device is substantially equivalent to legally marketed predicate devices for the indication of temporary increase of clear nail in patients with onychomycosis.
Therefore, I cannot extract the requested information based on the provided text. The document is administrative in nature, approving the device for marketing based on substantial equivalence, rather than detailing a performance study with acceptance criteria.
Ask a specific question about this device
Page 1 of 1